Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Danaher Corp
MedTech
Danaher buys patient monitoring specialist Masimo in $9.9B deal
Danaher Corp. is snapping up patient monitoring medtech Masimo in a $9.9 billion deal aimed at strengthening its diagnostics portfolio.
Natalie Missakian
Feb 18, 2026 3:05am
Cepheid to cut more than 600 jobs at Silicon Valley HQ
Aug 5, 2024 11:30am
Sherlock Bio links with IDT to ship its CRISPR coronavirus test
Jun 8, 2020 10:35am
In conversation with Emmanuel Ligner, head of the new Cytiva
Apr 1, 2020 10:10am
HemoCue launches in-office hemoglobin count system in the U.S.
Mar 1, 2019 2:21pm
GE to sell its biopharma business to Danaher for $21.4B
Feb 25, 2019 12:20pm
